Integra Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $12.5M

  • Investors
  • 7

Integra Therapeutics General Information

Description

Developer of gene-writing technologies designed to support therapies for cancer and autoimmune diseases. The company develops gene-writing tools for advanced therapies, focusing on therapeutic breadth, genetic modification efficiency, and treatment safety, with research directed at oncological and autoimmune conditions, enabling therapy developers to explore treatment options for diseases with unmet medical needs.

Contact Information

Website
www.integra-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Avenida Diagonal, 601
  • 8th Floor
  • 08028 Barcelona
  • Spain
+34 933
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Avenida Diagonal, 601
  • 8th Floor
  • 08028 Barcelona
  • Spain
+34 933

Integra Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Integra Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 08-Sep-2025 $12.5M Completed Generating Revenue
5. Grant 13-Mar-2024 Completed Generating Revenue
4. Grant 18-Apr-2023 Completed Generating Revenue
3. Early Stage VC 18-Jan-2023 Completed Generating Revenue
2. Seed Round 29-Mar-2022 $826K $3.39M Completed Generating Revenue
1. Seed Round 02-Dec-2021 $2.57M $2.57M Completed Generating Revenue
To view Integra Therapeutics’s complete valuation and funding history, request access »

Integra Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Integra Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Integra Therapeutics Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

Integra Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026087488-A1 Gene editing tools and compositions for cell engineering Pending 21-Oct-2024
WO-2024246338-A2 Novel transposases and uses thereof Inactive 01-Jun-2023
AU-2024278976-A1 Transposases and uses thereof Pending 01-Jun-2023
AU-2024278976-A9 Transposases and uses thereof Pending 01-Jun-2023
EP-4720269-A2 Transposases and uses thereof Pending 01-Jun-2023 C12N9/1241
To view Integra Therapeutics’s complete patent history, request access »

Integra Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Integra Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDTI Innvierte Government Minority
European Innovation Council Accelerator/Incubator Minority
INNVIERTE SICC Government
Columbus Venture Partners Venture Capital Minority
AdBio partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Integra Therapeutics FAQs

  • When was Integra Therapeutics founded?

    Integra Therapeutics was founded in 2020.

  • Where is Integra Therapeutics headquartered?

    Integra Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of Integra Therapeutics?

    Integra Therapeutics has 20 total employees.

  • What industry is Integra Therapeutics in?

    Integra Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Integra Therapeutics a private or public company?

    Integra Therapeutics is a Private company.

  • What is Integra Therapeutics’s current revenue?

    The current revenue for Integra Therapeutics is .

  • How much funding has Integra Therapeutics raised over time?

    Integra Therapeutics has raised $19.1M.

  • Who are Integra Therapeutics’s investors?

    CDTI Innvierte, European Innovation Council, INNVIERTE SICC, Columbus Venture Partners, and AdBio partners are 5 of 7 investors who have invested in Integra Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process